These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma]. Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477 [TBL] [Abstract][Full Text] [Related]
3. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Balch CM; Buzaid AC; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Houghton A; Kirkwood JM; Mihm MF; Morton DL; Reintgen D; Ross MI; Sober A; Soong SJ; Thompson JA; Thompson JF; Gershenwald JE; McMasters KM Cancer; 2000 Mar; 88(6):1484-91. PubMed ID: 10717634 [TBL] [Abstract][Full Text] [Related]
4. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF J Clin Oncol; 2001 Aug; 19(16):3635-48. PubMed ID: 11504745 [TBL] [Abstract][Full Text] [Related]
5. The revised American Joint Committee on Cancer staging system for melanoma. Thompson JA Semin Oncol; 2002 Aug; 29(4):361-9. PubMed ID: 12170439 [TBL] [Abstract][Full Text] [Related]
6. Current melanoma staging. Petro A; Schwartz J; Johnson T Clin Dermatol; 2004; 22(3):223-7. PubMed ID: 15262308 [TBL] [Abstract][Full Text] [Related]
7. Classification and staging of melanoma. Gershenwald JE; Buzaid AC; Ross MI Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515 [TBL] [Abstract][Full Text] [Related]
8. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma. Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885 [TBL] [Abstract][Full Text] [Related]
9. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123 [TBL] [Abstract][Full Text] [Related]
10. Implications of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification on dermatologists and their patients. Nading MA; Balch CM; Sober AJ Semin Cutan Med Surg; 2010 Sep; 29(3):142-7. PubMed ID: 21051007 [TBL] [Abstract][Full Text] [Related]
11. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma. Retsas S; Mastrangelo MJ Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372 [TBL] [Abstract][Full Text] [Related]
12. [The new TNM classification of malignant melanoma]. Oláh J; Dobozy A Magy Onkol; 2003; 47(1):59-61. PubMed ID: 12704456 [TBL] [Abstract][Full Text] [Related]
13. An evidence-based staging system for cutaneous melanoma. Balch CM; Soong SJ; Atkins MB; Buzaid AC; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF CA Cancer J Clin; 2004; 54(3):131-49; quiz 182-4. PubMed ID: 15195788 [TBL] [Abstract][Full Text] [Related]
14. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346 [TBL] [Abstract][Full Text] [Related]
16. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Keijzer R; Bril H; van der Loo EM; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391 [TBL] [Abstract][Full Text] [Related]
17. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma. Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596 [TBL] [Abstract][Full Text] [Related]
18. [Melanoma]. Saida T Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225 [TBL] [Abstract][Full Text] [Related]
19. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
20. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy. Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]